Arphra/Issuer/DHR

DHR

Danaher Corporation

HealthcareMedical - Diagnostics & ResearchUSUSD

$176.11

-0.89%LiveJun 02, 2026

AI Brief

Market cap

$124.65B

52w range

160.93 – 242.80

P / E

—

EPS

—

Volume

2.37M

Revenue · FY

$24.57B

+2.90% YoY

Explain this page

Arphra AIPlain-English read on Danaher Corporation’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Insider · 30d

Bought

0 txns

Sold

$107.74M

10 txns

Net flow

−$107.74M

Full history →

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$173.06

Change

-9.89%

Period high

$242.05

Period low

$173.06

Period start

$192.062025-06-03

Through 2026-05-04

Peers

Price change · trailing returns

Live

1D	5D	1M	3M	6M	YTD	1Y	3Y	5Y	10Y	Max
-2.09%	-2.73%	+0.55%	-13.68%	-22.91%	-23.07%	-8.30%	-14.77%	-17.56%	+166.71%	+29463.04%

Aftermarket

Live

Jun 02, 11:50 PM

Last trade

$175.86

295 sh

Bid

$175.34

1 sh

Ask

$176.38

23 sh

Spread

$1.040

Sector & industry today

Live

Sectors

Technology
+1.59%
Industrials
+1.50%
Energy
+1.40%
Basic Materials
+1.36%
Utilities
+0.94%
Consumer Cyclical
+0.45%
Real Estate
+0.37%
Consumer Defensive
+0.28%
Financial Services
+0.05%
Healthcare
-0.26%
Communication Services
-0.39%

Top industries (issuer's industry highlighted)

Medical - Diagnostics & Research
-0.90%
Hardware, Equipment & Parts
+5.17%
Computer Hardware
-4.64%
REIT - Office
+4.28%
Communication Equipment
+4.02%
Electronic Gaming & Multimedia
-3.94%
Real Estate - Services
+3.82%
Agricultural - Machinery
+3.64%
Auto - Parts
+3.58%
Oil & Gas Energy
+3.45%
Information Technology Services
+3.19%
Copper
+3.00%

Fair value

Football field →

Weighted blend

$223.97

+27.17% vs spot

Recommendation

Strong Buy

18 of 19 methods

Method spread

5bull13bear

±5% threshold

Analyst PT consensus: $247.00 (+40.25%)

Total assets

$83.46B

Total debt

$18.42B

Cash & equiv

$4.62B

Operating CF

$6.42B

Free cash flow

$5.26B

Buybacks

-$3.09B

Analyst view

DB · price_targets + analyst_grades

Consensus target

$247.00

+40.25% upside

Low

$205.00

Median

$249.00

High

$270.00

Recent actions

0 ↑0 ↓8 hold

Apr 01, 2026
Mar 01, 2026
Feb 01, 2026
Jan 01, 2026
Dec 01, 2025

News

DB · news_items

Recent quarters

All financials →

Period	Revenue	Net income	EPS
Q1 Mar 2026	$5.95B	$1.03B	$1.45
Q4 Dec 2025	$6.84B	$1.2B	$1.68
Q3 Sep 2025	$6.05B	$908M	$1.27
Q2 Jun 2025	$5.94B	$555M	$0.77
Q1 Mar 2025	$5.74B	$954M	$1.32
Q4 Dec 2024	$6.54B	$1.09B	$1.49

Recent insiders

All →

Insider	Action	Shares	Value	Date
SPOON ALAN G director	Sell	1,358	$237.21K	May 01, 2026
Milosevich Gregory M officer: Executive Vice President	Sell	1,320	$274.57K	Feb 19, 2026
RALES MITCHELL P director, officer: Chairman of Exec. Committee	Sell	4,726	$1.09M	Nov 25, 2025
RALES MITCHELL P director, officer: Chairman of Exec. Committee	Sell	35,899	$8.27M	Nov 25, 2025
List Teri director	Sell	3,298	$747K	Nov 18, 2025
RALES MITCHELL P director, officer: Chairman of Exec. Committee	Sell	254,553	$55.56M	Nov 12, 2025

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2025	$24.57B	$5.14B	$3.61B	$5.04	+14.71%
FY 2024	$23.88B	$5.18B	$3.9B	$5.29	+16.33%
FY 2023	$23.89B	$5.28B	$4.76B	$6.38	+19.94%
FY 2022	$26.64B	$7.54B	$7.21B	$9.64	+27.06%
FY 2021	$29.45B	$8.05B	$6.43B	$8.61	+21.84%